Multi-Step Synthesis of Biologically Active Novel N-Benzyl-3,5-Bis(Arylidene)-Piperidin-4-Ones and Some Derived Bicyclic and Tricyclic Ring Systems as Macromolecules

References

• M. Gallorini, A. Cataldi, and V. di Giacomo, “Cyclin-Dependent Kinase Modulators and Cancer Therapy,” BioDrugs: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy 26, no. 6 (2012): 377–91.
   PubMed Web of Science ®Google Scholar
• P. Cozzi, “The Discovery of a New Potential Anticancer Drug: A Case History,” Farmaco (Societa Chimica Italiana: 1989) 58, no. 3 (2003): 213–20.
   PubMedGoogle Scholar
• S. Eckhardt, “Recent Progress in the Development of Anticancer Agents,” Current Medicinal Chemistry - Anti-Cancer Agents 2, no. 3 (2002): 419–39.
   PubMedGoogle Scholar
• E. Akbas and I. Berber, “Antibacterial and Antifungal Activities of New Pyrazolo[3,4-d]Pyridazin Derivatives,” European Journal of Medicinal Chemistry 40, no. 4 (2005): 401–5.
   PubMed Web of Science ®Google Scholar
• G. Liang, L. Shao, Y. Wang, C. Zhao, Y. Chu, J. Xiao, Y. Zhao, X. Li, and S. Yang, “Exploration and Synthesis of Curcumin Analogues with Improved Structural Stability Both In Vitro and In Vivo as Cytotoxic Agents,” Bioorganic & Medicinal Chemistry 17, no. 6 (2009): 2623–31.
   PubMed Web of Science ®Google Scholar
• M. A. Bill, C. Bakan, D. M. Benson, J. Fuchs, G. Young, and G. B. Lesinski, “Curcumin Induces Proapoptotic Effects against Human Melanoma Cells and Modulates the Cellular Response to Immunotherapeutic Cytokines,” Molecular Cancer Therapeutics 8, no. 9 (2009): 2726–35.
   PubMed Web of Science ®Google Scholar
• L. R. Ferguson and M. Philpott, “Cancer Prevention by Dietary Bioactive Components That Target the Immune Response,” Current Cancer Drug Targets 7, no. 5 (2007): 459–64.
   PubMed Web of Science ®Google Scholar
• C. Jobin, C. A. Bradham, M. P. Russo, B. Juma, A. S. Narula, D. A. Brenner, and R. B. Sartor, “Curcumin Blocks Cytokine-Mediated NF-κB Activation and Proinflammatory Gene Expression by Inhibiting Inhibitory Factor I-κB Kinase Activity,” The Journal of Immunology 163, no. 6 (1999): 3474–83.
   PubMed Web of Science ®Google Scholar
• S. Kumar, U. Narain, S. Tripathi, and K. Misra, “Syntheses of Curcumin Bioconjugates and Study of Their Antibacterial Activities against β-Lactamase-Producing Microorganisms,” Bioconjugate Chemistry 12, no. 4 (2001): 464–9.
   PubMed Web of Science ®Google Scholar
• T. Kálai, M. L. Kuppusamy, M. Balog, K. Selvendiran, B. K. Rivera, P. Kuppusamy, and K. Hideg, “Synthesis of N-Substituted 3,5-Bis(Arylidene)-4-Piperidones with High Antitumor and Antioxidant Activity,” Journal of Medicinal Chemistry 54, no. 15 (2011): 5414–21.
   PubMed Web of Science ®Google Scholar
• J. Sun, S. Zhang, C. Yu, G. Hou, X. Zhang, K. Li, and F. Zhao, “Design, Synthesis and Bioevaluation of Novel N-Substituted-3,5-Bis(Arylidene)-4-Piperidone Derivatives as Cytotoxic and Antitumor Agents with Fluorescent Properties,” Chemical Biology & Drug Design 83, no. 4 (2014): 392–400.
   PubMed Web of Science ®Google Scholar
• D.-Y. Zhou, K. Zhang, A. H. Conney, N. Ding, X.-X. Cui, H. Wang, M. Verano, S.-Q. Zhao, Y.-X. Fan, X. Zheng, et al. “Synthesis and Evaluation of Curcumin-Related Compounds Containing Benzyl Piperidone for Their Effects on Human Cancer Cells,” Chemical & Pharmaceutical Bulletin 61, no. 11 (2013): 1149–55.
   PubMed Web of Science ®Google Scholar
• S. Das, U. Das, P. Selvakumar, R. K. Sharma, J. Balzarini, E. De Clercq, J. Molnár, J. Serly, Z. Baráth, G. Schatte, et al. “3,5‐Bis(Benzylidene)‐4‐Oxo‐1‐Phosphonopiperidines and Related Diethyl Esters: Potent Cytotoxins with Multi‐Drug‐Resistance Reverting Properties,” ChemMedChem 4, no. 11 (2009): 1831–40.
   PubMed Web of Science ®Google Scholar
• K. Singaram, D. Marimuthu, S. Baskaran, and V. Ramaswamy, “Synthesis and Antimicrobial Activity of New 3,5-Diarylidene-4-Piperidone Derivatives,” Journal of the Serbian Chemical Society 81, no. 8 (2016): 859–70.
   Web of Science ®Google Scholar
• M. A. Al‐Omar, K. M. Youssef, M. A. El‐Sherbeny, S. A. A. Awadalla, and H. I. El-Subbagh, “Synthesis and In Vitro Antioxidant Activity of Some New Fused Pyridine Analogs,” Archiv der Pharmazie 338, no. 4 (2005): 175–80.
   PubMed Web of Science ®Google Scholar
• S. A. Rostom, H. M. Faidallah, and M. S. Al-Saadi, “A Facile Synthesis of Some 3-Cyano-1,4,6-Trisubstituted-2(1H)-Pyridinones and Their Biological Evaluation as Anticancer Agents,” Medicinal Chemistry Research 20, no. 8 (2011): 1260–72.
   Web of Science ®Google Scholar
• H. M. Faidallah, K. A. Khan, and A. M. Asiri, “Synthesis of Some New 2-Oxo-1,4-Disubstituted-1,2,5,6-Tetrahydro-Benzo[h]Quinoline-3-Carbonitriles and Their Biological Evaluation as Cytotoxic and Antiviral Agents,” Journal of Chemical Sciences 124, no. 3 (2012): 625–31.
   Web of Science ®Google Scholar
• H. M. Faidallah, S. A. Rostom, K. A. Khan, and S. A. Basaif, “Synthesis and Characterization of Some Hydroxypyridone Derivatives and Their Evaluation as Antimicrobial Agents,” Journal of Enzyme Inhibition and Medicinal Chemistry 28, no. 5 (2013): 926–35.
   PubMed Web of Science ®Google Scholar
• H. M. Faidallah and S. A. Rostom, “Synthesis, In Vitro Antitumor Evaluation and DNA-Binding Study of Novel Tetrahydroquinolines and Some Derived Tricyclic and Tetracyclic Ring Systems,” European Journal of Medicinal Chemistry 63 (2013): 133–43.
   PubMed Web of Science ®Google Scholar
• H. M. Faidallah, S. A. Rostom, A. M. Asiri, K. A. Khan, M. F. Radwan, and H. Z. Asfour, “3-Cyano-8-Methyl-2-Oxo-1,4-Disubstituted-1,2,5,6,7,8-Hexahydroquinolines: Synthesis and Biological Evaluation as Antimicrobial and Cytotoxic Agents,” Journal of Enzyme Inhibition and Medicinal Chemistry 28, no. 1 (2013): 123–30.
   PubMed Web of Science ®Google Scholar
• H. M. Faidallah, A. A. Saqer, K. A. Alamry, K. A. Khan, and A. M. Asiri, “Synthesis and Biological Evaluation of Some Novel Tetrahydroquinolines as Anticancer and Antimicrobial Agents,” Journal of Enzyme Inhibition and Medicinal Chemistry 29, no. 3 (2014): 367–78.
   PubMed Web of Science ®Google Scholar
• H. M. Faidallah and S. S. Al-Juaid, “Fast and Green Synthesis of 3-Cyano-8-Methyl-2-Oxo-4-Substituted 1,” Chemistry and Technology of Fuels and Oils 50, no. 3 (2014): 240–7.
   Web of Science ®Google Scholar
• H. M. Faidallah, S. A. Rostom, M. H. Badr, A. E. Ismail, and A. M. Almohammadi, “Synthesis of Some 1,4,6-Trisubstituted-2-oxo-1,2-dihydropyridine-3-carbonitriles and Their Biological Evaluation as Cytotoxic and Antimicrobial Agents,” Archiv der Pharmazie 348, no. 11 (2015): 824–34.
   PubMed Web of Science ®Google Scholar
• H. M. Faidallah, S. A. Rostom, and K. A. Khan, “Synthesis of Some Polysubstituted Nicotinonitriles and Derived Pyrido[2,3-d] Pyrimidines as In Vitro Cytotoxic and Antimicrobial Candidates,” Journal of Chemistry 2016 (2016): 1–12.
   Web of Science ®Google Scholar
• A. M. Asiri, H. M. Faidallah, A. O. Al-Youbi, M. N. Arshad, O. I. Osman, and M. E. Zayed, “An Efficient Approach towards the Synthesis, Crystal Structures, DFT and Cytotoxic Activity of Highly Congested 11-Aryl-10,12-Dihydrodiindino[1,2-b′,2′,1′-e] Pyridine,” Journal of Chemical Research 40, no. 7 (2016): 428–35.
   Web of Science ®Google Scholar
• F. Denizot and R. Lang, “Rapid Colorimetric Assay for Cell Growth and Survival: Modifications to the Tetrazolium Dye Procedure Giving Improved Sensitivity and Reliability,” Journal of Immunological Methods 89, no. 2 (1986): 271–7.
   PubMed Web of Science ®Google Scholar
• S. Morosawa, “Studies on Seven-Membered Heterocyclic Compounds Containing Nitrogen. II. An Improved Synthesis of 1-Azacycloheptan-4-One and Its Related Compounds,” Bulletin of the Chemical Society of Japan 31, no. 4 (1958): 418–22.
   Web of Science ®Google Scholar
• T. Mosmann, “Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays,” Journal of Immunological Methods 65, no. 1–2 (1983): 55–63.
   PubMed Web of Science ®Google Scholar